XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net loss $ (184,120) $ (125,229)
Adjustments to reconcile net loss to cash provided by operating activities:    
Depreciation and amortization 138,490 133,194
Net amortization of debt discounts, premiums and issuance costs 50,454 4,323
Straight line rental income (947) 2,009
Amortization of acquired real estate leases and other intangible assets, net 57 (286)
Loss on modification or early extinguishment of debt 209 1,075
Impairment of assets 18,687 17,224
Loss (gain) on sale of properties 19,087 (1,233)
Gains on equity securities, net 0 (8,126)
Other non-cash adjustments, net (387) (1,051)
Unconsolidated joint venture distributions 1,231 2,640
Equity in net losses (earnings) of investees 10,409 (2,282)
Change in assets and liabilities:    
Deferred leasing costs, net (1,106) (4,071)
Other assets 23,643 29,992
Accrued interest 380 (1,202)
Other liabilities (3,193) (15,254)
Net cash provided by operating activities 72,894 31,723
Cash flows from investing activities:    
Real estate improvements (87,720) (107,934)
Proceeds from sale of properties, net 7,318 3,548
Investment in AlerisLife Inc. (15,459) 0
Proceeds from insurance recoveries 170 0
Proceeds from AlerisLife Inc. tender offer 0 14,006
Net cash used in investing activities (95,691) (90,380)
Cash flows from financing activities:    
Proceeds from mortgage notes payable 120,000 0
Repayments of borrowings on credit facility 0 (250,000)
Redemption of senior unsecured notes (60,000) 0
Repayment of other debt (1,586) (15,678)
Payment of debt issuance costs (7,564) (2,057)
Repurchase of common shares (121) (33)
Distributions to shareholders (4,808) (4,794)
Net cash provided by (used in) financing activities 45,921 (272,562)
Increase (decrease) in cash and cash equivalents and restricted cash 23,124 (331,219)
Cash and cash equivalents and restricted cash at beginning of period 246,961 688,302
Cash and cash equivalents and restricted cash at end of period $ 270,085 $ 357,083